Find News

Filter articles

Showing 3151 to 3160 of 3417 results

HGF promotes Nelson to partner


HGF has promoted Mike Nelson to partner. He joined the firm last year to work with the pharmaceutical and chemistry teams after arriving from AstraZeneca.

US hits out at Indian pharma patent protection

India, US01-05-2014

Patent protection in the pharmaceutical sector in India has raised “serious” concerns, the US government said yesterday, April 30, in its annual Special 301 Report.

Cephalon launches another Treanda action


Cephalon has filed another lawsuit to protect its chronic lymphocytic leukaemia and non-Hodgkin’s lymphoma treatment Treanda (bendamustine hydrochloride), this time against Canadian pharmaceutical company Uman Pharma.

Actavis and Pfizer settle Celebrex litigation

US29-04-2014Legal developments

Actavis has entered into an agreement with Pfizer to settle all outstanding patent litigation related to Pfizer’s arthritis drug Celebrex (celecoxib).

AstraZeneca ‘has value’ says former Pfizer lawyer

UK, US28-04-2014Mergers & acquisitions

AstraZeneca’s portfolio does not appear to offer a long pipeline of marketed products with long periods of exclusivity, says Jason Rutt, head of the patents group at Rouse in London and former head of Pfizer’s UK patent department.

Federal Circuit rules against Roche in Tamiflu case

India, US25-04-2014Legal developments

The US Court of Appeals for the Federal Circuit has thrown out a lower court ruling that found Natco Pharma infringed a patent covering Roche’s flu drug Tamiflu (oseltamivir phosphate).

Pfizer criticises Indian pharma patent policy

India, US25-04-2014

Pfizer’s associate general counsel, Justin McCarthy, has sent a letter to India’s ambassador to the US, Subrahmanyam Jaishankar, urging the Indian government to “shift from using destructive IP policy as an access strategy,” according to reports.

Novartis and GSK team in $14.5b IP exchange

Switzerland, UK23-04-2014Mergers & acquisitions

Novartis and GSK have agreed to create a consumer healthcare business in a joint venture that involves the exchange of assets worth billions of dollars.

Depomed settles with generics over Gralise dispute

US16-04-2014Legal developments

Depomed, a California-based pharmaceutical company, has settled litigation with two of three companies that sought to launch generic versions of its Gralise (gabapentin) product before patents covering it expire.

Aurobindo Pharma sued over Angiomax


US-based The Medicines Co has sued Aurobindo Pharma after claims the Indian pharmaceutical company infringed two patents related to its heart drug Angiomax (bivalirudin).

Showing 3151 to 3160 of 3417 results